Ventrinova
New York, New York, United States · Founded 2006
About Ventrinova
VentriNova is a regenerative medicine company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells. VentriNova’s first generation product is a gene therapy that delivers a critical mitotic regulator to diseased heart tissue to stimulate proliferation of cardiac muscle cells.
Company Facts
- Founded: 2006
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Seed (Sep 2009)
- Website: http://www.ventrinovainc.com/
- Phone: +1 508-362-3087
Industries & Categories
Clinical Trials, Genetics, Therapeutics
Canonical: https://fsome.com/organization/ventrinova-2563926 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.